Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
viviana.frantellizzi@uniroma1.it
Viviana Frantellizzi
Ricercatore
Struttura:
DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
E-mail:
viviana.frantellizzi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Radium-223 treatment in mcrpc patient with polycythemia vera
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
2021
Radiotheranostic agents targeting neuroblastoma: state-of-the-art and emerging perspectives
CANCERS
2021
99mTc-labeled Keratin-coated gold nanoparticles for selective anticancer photothermal therapy
Optical Molecular Probes, Imaging and Drug Delivery - OTu1E - Molecular Contrast Agents and Probes
2021
Impact of the first wave of coronavirus disease 2019 (COVID-19) pandemic on the diagnosis of heart disease in the Russian Federation: results from the Russian segment of the IAEA INCAPS COVID study
ROSSIJSKIJ KARDIOLOGICESKIJ ZURNAL
2021
Correction (Journal of the American College of Cardiology (2021) 77(2) (173–185), (S0735109720378694), (10.1016/j.jacc.2020.10.054)
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2021
Impact of COVID-19 pandemic on cardiovascular testing in Asia: the IAEA INCAPS-COVID study
JACC. ASIA
2021
Dosimetric principles of targeted radiotherapy and radioimmunotherapy
Nuclear Medicine and Immunology
2021
Analysis of unusual adverse effects after radium-223 dichloride administration
CURRENT RADIOPHARMACEUTICALS
2020
Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment
RADIOLOGY AND ONCOLOGY
2020
Primary radical prostatectomy or ablative radiotherapy (RP/EBRT) are protective factors in mCRPC patients treated with 223radium-dichloride. An Italian multicenter study
CLINICAL GENITOURINARY CANCER
2020
Target alpha therapy with Thorium-227
CANCER BIOTHERAPY & RADIOPHARMACEUTICALS
2020
Neuroimaging in vascular cognitive impairment and dementia: a systematic review
JOURNAL OF ALZHEIMER'S DISEASE
2020
New frontiers in molecular imaging with superparamagnetic iron oxide nanoparticles (SPIONs): efficacy, toxicity, and future applications
NUCLEAR MEDICINE AND MOLECULAR IMAGING
2020
Role of nuclear imaging in cardiac amyloidosis management: clinical evidence and review of literature
CURRENT MEDICAL IMAGING REVIEWS
2020
Usefulness of 5 minutes 123I-mIBG scan in Parkinson's disease and heart failure
CURRENT RADIOPHARMACEUTICALS
2020
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2020
The 123I-mIBG heart/mediastinum ratio: moving from 2D to 3D imaging
JOURNAL OF NUCLEAR CARDIOLOGY
2020
Baseline quality of life predicts overall survival in patients with mCRPC treated with 223Ra-dichloride
HELLENIC JOURNAL OF NUCLEAR MEDICINE
2020
123I-FP-CIT brain SPECT findings in succinic semialdehyde dehydrogenase (SSADH) deficiency
CURRENT RADIOPHARMACEUTICALS
2020
The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation
EUROPEAN HEART JOURNAL. CARDIOVASCULAR IMAGING
2020
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
seguente ›
ultima »
ERC
LS7_1
KET
Life-science technologies & biotechnologies
Keywords
nuclear medicine and imaging
molecular imaging
iodine radioisotopes
Gruppi di ricerca
Gruppo di ricerca sull'amiloidosi sistemica da transtiretina
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma